Delivery Order SPE2DB22D2006-SPE2DB25FW2MW
- Not listed
- The Defense Logistics Agency awarded a $36,826.65 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of XELJANZ XR 11 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. This delivery order represents a single...
- The Defense Logistics Agency awarded a delivery order valued at $13,322.71 to AmerisourceBergen Drug Corp for XELJANZ XR 11 mg tablets (30-count units) on August 6, 2025, with completion expected by August 7, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a continuation of AmerisourceBergen's pharmaceutical supply relationship with DLA. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of XELJANZ XR 11 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $15,662.64, represents a competitively awarded contract with no set-aside designation and is scheduled for completion by July 25, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $20,369.56 delivery order to AmerisourceBergen Drug Corp for XELJANZ XR 11 mg tablets (30-count packaging) on July 28, 2025, with an ultimate completion date of July 29, 2025. This non-set-aside, competitively awarded contract employs firm fixed-price terms and represents a child delivery order under AmerisourceBergen's larger contract vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $11,428.25 to AmerisourceBergen Drug Corp for XELJANZ XR 11 mg tablets (30-count unit of use packaging) on August 29, 2025, with completion scheduled for September 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a small-value pharmaceutical supply transaction for federal medical procurement. The work will be performed at AmerisourceBergen's corporate headquarters...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of XELJANZ XR 11 mg tablets in quantities of 30 units. This is a firm fixed price delivery order valued at $25,624.50, with performance completion scheduled for September 15, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award was not designated as a set-aside contract and represents a competitively...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $38,053.59 on September 11, 2025, for the supply of XELJANZ XR 11 mg tablets in quantities of 30s. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under the company's existing contract vehicle with DLA. The pharmaceutical products will be delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of September...
- The Defense Logistics Agency awarded a $34.7K firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for supply of XELJANZ XR 11 mg tablets in quantities of 30 count units. The contract, which is not set-aside and carries an ultimate completion date of July 23, 2025, represents a single delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $5,960.70 delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of XELJANZ XR 11 mg tablets (30-unit bottles). This firm fixed price delivery order, with an ultimate completion date of June 23, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a $15,013.38 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of XELJANZ XR 11 mg tablets in quantities of 30-count units. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The order is scheduled for completion by September 4, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW2MWDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,065.82 on July 14, 2025, for the supply of XELJANZ XR 11 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 15, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor, AmerisourceBergen holds a significant position within the federal medical supply chain and regularly fulfills orders for specialized therapeutics across multiple domains through competitively awarded delivery orders under this framework agreement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 7/14/25 |